The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene

被引:165
作者
Lagger, G
Doetzlhofer, A
Schuettengruber, B
Haidweger, E
Simboeck, E
Tischler, J
Chiocca, S
Suske, G
Rotheneder, H
Wintersberger, E
Seiser, C
机构
[1] Univ Vienna, Inst Med Biochem, Div Mol Biol, Vienna Bioctr, A-1030 Vienna, Austria
[2] Ist Europeo Oncol, Dept Expt Oncol, I-20141 Milan, Italy
[3] Univ Marburg, Inst Mol Biol & Tumor Res, Marburg, Germany
关键词
D O I
10.1128/MCB.23.8.2669-2679.2003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The cyclin-dependent kinase inhibitor p21/WAF1/CIP1 is an important regulator of cell cycle progression, senescence, and differentiation. Genotoxic stress leads to activation of the tumor suppressor p53 and subsequently to induction of p21 expression. Here we show that the tumor suppressor p53 cooperates with the transcription factor Sp1 in the activation of the p21 promoter, whereas histone deacetylase 1 (HDAC1) counteracts p53-induced transcription from the p21 gene. The p53 protein binds directly to the C terminus of Sp1, a domain which was previously shown to be required for the interaction with HDAC1. Induction of p53 in response to DNA-damaging agents resulted in the formation of p53-Sp1 complexes and simultaneous dissociation of HDAC1 from the C terminus of Sp1. Chromatin immunoprecipitation experiments demonstrated the association of HDAC1 with the p21 gene in proliferating cells. Genotoxic stress led to recruitment of p53, reduced binding of HDAC1, and hyperacetylation of core histones at the p21 promoter. Our findings show that the deacetylase HDAC1 acts as an antagonist of the tumor suppressor p53 in the regulation of the cyclin-dependent kinase inhibitor p21 and provide a basis for understanding the function of histone deacetylase inhibitors as antitumor drugs.
引用
收藏
页码:2669 / 2679
页数:11
相关论文
共 68 条
[41]   Negative control of p53 by Sir2α promotes cell survival under stress [J].
Luo, JY ;
Nikolaev, AY ;
Imai, S ;
Chen, DL ;
Su, F ;
Shiloh, A ;
Guarente, L ;
Gu, W .
CELL, 2001, 107 (02) :137-148
[42]   Effects of histone acetylation on transcriptional regulation of manganese superoxide dismutase gene [J].
Maehara, K ;
Uekawa, N ;
Isobe, KI .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 295 (01) :187-192
[43]  
Marks PA, 2001, CLIN CANCER RES, V7, P759
[44]   Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a [J].
Murphy, M ;
Ahn, J ;
Walker, KK ;
Hoffman, WH ;
Evans, RM ;
Levine, AJ ;
George, DL .
GENES & DEVELOPMENT, 1999, 13 (19) :2490-2501
[45]   Multiple lysine mutations in the C-terminal domain of p53 interfere with MDM2-dependent protein degradation and ubiquitination [J].
Nakamura, S ;
Roth, JA ;
Mukhopadhyay, T .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (24) :9391-9398
[46]   Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line [J].
Nakano, K ;
Mizuno, T ;
Sowa, Y ;
Orita, T ;
Yoshino, T ;
Okuyama, Y ;
Fujita, T ;
OhtaniFujita, N ;
Matsukawa, Y ;
Tokino, T ;
Yamagishi, H ;
Oka, T ;
Nomura, H ;
Sakai, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (35) :22199-22206
[47]   CLONING OF SENESCENT CELL-DERIVED INHIBITORS OF DNA-SYNTHESIS USING AN EXPRESSION SCREEN [J].
NODA, A ;
NING, Y ;
VENABLE, SF ;
PEREIRASMITH, OM ;
SMITH, JR .
EXPERIMENTAL CELL RESEARCH, 1994, 211 (01) :90-98
[48]   p53 regulates insulin-like growth factor-I (IGF-I) receptor expression and IGF-I-induced tyrosine phosphorylation in an osteosarcoma cell line: Interaction between p53 and Sp1 [J].
Ohlsson, C ;
Kley, N ;
Werner, H ;
LeRoith, D .
ENDOCRINOLOGY, 1998, 139 (03) :1101-1107
[49]   Regulation of the p53 tumor suppressor protein [J].
Oren, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (51) :36031-36034
[50]   Why is p53 acetylated? [J].
Prives, C ;
Manley, JL .
CELL, 2001, 107 (07) :815-818